http://www.fpnotebook.com/
NordetteAka: Monofeme, Levlen
- See Also
- Preparations (Levonorgestrel / Ethinyl Estradiol)
- Nordette (0.15 / 30)
- Monofeme (0.15 / 30)
- Levlen (0.15 / 30)
- Seasonale (0.15 / 30)
- Components
- Levonorgestrel 0.15 mg (see preparation above)
- Ethinyl Estradiol 30 ug
- Effect
- Relative Progestational Activity: 0.8 (moderate)
- Estrogenic Activity: 25 (moderate)
- Androgenic Activity: 0.46 (high)
- Pill associated problems
- Indications to switch to Ortho Cyclen
- Acne Vulgaris (lower androgen)
- Increased Appetite (lower Progestin)
- Major Depression provoked (lower Progestin)
- Indications to switch to Loestrin 1.5/30
- Indications to switch to Ortho Novum 1/35
- Indications to switch to Estrostep
- Break-through bleed days 10-21 (more Progestin)
- Heavy Menses (more Progestin or less Estrogen)
- Dysmenorrhea or Menstrual Cramps (more Progestin)
- Indications to switch to Ortho Cyclen
- References
- Cerel-Suhl (1999) Am Fam Physician 60(7):2073
- Speroff (1993) Obstet Gynecol 81:1034
- Dickey (1998) Managing Contraceptive Pill Patients
Levlen (C0721338) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125) |
| English | Levlen |
| Sources | RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Nordette (C0733743) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125) |
| MSH | D019304 |
| English | Nordette |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |